Domain of Expertise: Swiss Healthcare Policy and Regulatory Compliance
Expert Persona: Top-Tier Senior Analyst in Swiss Healthcare Policy
Abstract
The Federal Department of Home Affairs (EDI) has mandated several critical amendments to the Ordinance on Healthcare Services (KLV) and its corresponding appendices, effective in two phases starting July 1, 2025, and January 1, 2026. The most significant financial change is the exemption of specific KLV-listed vaccinations from the deductible (Franchise), aimed at boosting national vaccination rates. Simultaneously, administrative simplification measures will reduce bureaucracy for chronically ill patients regarding necessary supplies (MiGeL), and coverage for colorectal cancer screening will be expanded to individuals up to age 74. Furthermore, mandatory health insurance (OKP) will cover the RSV vaccine for pregnant women to ensure protection for newborns.
Regulatory Summary: Amendments to the Swiss Ordinance on Healthcare Services (KLV)
The following regulatory changes, decided by the Federal Department of Home Affairs (EDI), detail revisions to the reimbursement structure and service coverage under the Mandatory Health Insurance (OKP):
Effective July 1, 2025: Expansion of Colorectal Cancer (KRK) Screening Coverage.
Colorectal cancer screening, utilizing fecal occult blood tests and/or colonoscopies, will be covered for individuals up to 74 years of age.
Detail: This expands the existing coverage, which was limited to individuals between 50 and 69 years, recognizing that approximately 50% of KRK cases are diagnosed after age 70.
Limitation: Screening for individuals over 74 remains excluded due to unclear benefits amidst heightened risks from co-morbidities.
Effective July 1, 2025: Administrative Relief for Chronically Ill Patients.
The annual requirement for chronically ill patients to demonstrate the supplementary need for certain supplies and objects listed in the MiGeL (List of Supplies and Objects) will be eliminated in several chapters.
Rationale: This change addresses unnecessary administrative burden for patients with stable chronic conditions, deemed neither economical nor practical, with the risk of misuse considered very low.
Effective July 1, 2025: Introduction of RSV Vaccine Coverage.
The OKP will cover the Respiratory Syncytial Virus (RSV) vaccine for pregnant women.
Goal: To ensure newborns are protected against RSV from birth through maternal antibody transfer.
Effective January 1, 2026: Exemption of Vaccinations from the Deductible (Franchise).
All specified vaccinations listed under Article 12a KLV (including, but not limited to, diphtheria, tetanus, pneumococci, and meningococci) and associated professional counseling will be exempt from the deductible.
Policy Goal: This measure is part of the National Vaccination Strategy Action Plan, intended to increase the national vaccination rate.
Financial Detail: The policy change does not alter the mandatory co-payment (Selbstbehalt) for insured persons.
Timing Context: This deductible exemption will be synchronized with the implementation of the new comprehensive tariff system for outpatient medical services, which includes the TARDOC single-service tariff structure and new outpatient flat rates.